AstraZeneca

IPO initial public offering Wall Street
Health Tech

Tempus AI aims to raise $400M in IPO

The Chicago-based company is looking to raise as much as $410.7 million by selling 11.1 million shares at a price range of $35 to $37 a share.
Heather Landi Jun 7, 2024 7:00am
People shaking hands across a desk that has computer and papers on it

Pfizer taps Tempus' AI for cancer drug development

Mar 2, 2023 7:23am
Prescription Drugs and Money image

Federal appeals court hands pharma a win on 340B restrictions

Jan 31, 2023 12:50pm
Gavel and flag in courtroom

24 states support feds in 340B drugmaker lawsuit

May 17, 2022 7:50am
Drug prices

J&J to cut off 340B discounts to pharmacies starting in May

Mar 22, 2022 3:10pm
Gavel and flag in courtroom

Judge sides with AstraZeneca in 340B contract pharmacy lawsuit

Feb 17, 2022 1:09pm